Your browser doesn't support javascript.
loading
Early response does not predict outcome in children and adolescents with chronic myeloid leukaemia treated with high-dose imatinib.
Giona, Fiorina; Saglio, Giuseppe; Santopietro, Michelina; Menna, Giuseppe; Putti, Maria Caterina; Micalizzi, Concetta; Iaria, Grazia; Santoro, Nicola; Ladogana, Saverio; Mura, Rosamaria; Burnelli, Roberta; Consarino, Caterina; Cosmi, Carlo; Moleti, Maria Luisa; Leszl, Anna; Tucci, Francesca; Nanni, Mauro; Diverio, Daniela; Biondi, Andrea; Locatelli, Franco; Foà, Robin.
Afiliación
  • Giona F; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University, Rome, Italy.
  • Saglio G; Department of Clinical and Biological Sciences, University of Turin at Orbassano, Turin, Italy.
  • Santopietro M; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University, Rome, Italy.
  • Menna G; Paediatric Haematology Unit, Santobono-Pausilipon Hospital, Naples, Italy.
  • Putti MC; Department of Women's and Children's Health,  Padova University Hospital, Padua, Italy.
  • Micalizzi C; Clinical Experimental Haematology Unit, Gaslini Research Institute, Genoa, Italy.
  • Iaria G; Division of Haematology, Bianchi-Melacrino-Morelli Hospital, Reggio Calabria, Italy.
  • Santoro N; U.O. di Oncologia ed Ematologia Oncologica Pediatrica, Policlinico, Bari, Italy.
  • Ladogana S; Department of Paediatrics, "Casa Sollievo della Sofferenza" Hospital, San Giovanni Rotondo, Italy.
  • Mura R; Paediatric Haemato-Oncology Unit, Ospedale Regionale per le Microcitemie, Cagliari, Italy.
  • Burnelli R; Department of Reproduction and Growth, University Hospital Sant'Anna in Ferrara, Ferrara, Italy.
  • Consarino C; Haemato-Oncology Unit, Azienda Ospedaliera "Pugliese-Ciaccio", Catanzaro, Italy.
  • Cosmi C; Paediatric Unit, Ospedale di Sassari, Sassari, Italy.
  • Moleti ML; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University, Rome, Italy.
  • Leszl A; Clinical Experimental Haematology Unit, Gaslini Research Institute, Genoa, Italy.
  • Tucci F; Paediatric Haematology Unit, Santobono-Pausilipon Hospital, Naples, Italy.
  • Nanni M; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University, Rome, Italy.
  • Diverio D; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University, Rome, Italy.
  • Biondi A; Department of Paediatrics, University of Milano-Bicocca, Monza, Italy.
  • Locatelli F; Dipartimento di Oncoematologia Pediatrica, IRCCS Ospedale Bambino Gesù, Rome, Italy.
  • Foà R; Dipartimento di Scienze Pediatriche Università di Pavia, Italy.
Br J Haematol ; 180(6): 895-898, 2018 03.
Article en En | MEDLINE | ID: mdl-27984633
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Mesilato de Imatinib Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Br J Haematol Año: 2018 Tipo del documento: Article País de afiliación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Mesilato de Imatinib Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Br J Haematol Año: 2018 Tipo del documento: Article País de afiliación: Italia